My indepth story on possible misconduct by Seattle prosecutors published by The Intercept

by | Apr 18, 2018 | conflicts of interest, human trafficking, law enforcement, media coverage, prostitution, sex trafficking, sex work, trafficking, Uncategorized, underage prostitution

A few months ago, I was given access to hundreds of internal documents that had been obtained from the King County prosecutor’s office and other law enforcement in the Seattle area by public records requests. The documents revealed that prosecutors and police in...

A review of two new books that attack the DSM-5, psychiatry’s “bible”

by | Jun 10, 2013 | antidepressants, antipsychotic drugs, conflicts of interest, drug marketing, FDA, pharmaceutical industry, prescription drug abuse, scientific misconduct

I reviewed two books now circulating about the DSM and the current controversy over the DSM-5 for The American Scholar — see review here. The two books are The Book of Woe: The DSM and the Unmaking of Psychiatry by Gary Greenberg, and Saving Normal: An Insider’s...

Martin Keller, principal investigator of Paxil study 329, retires from Brown University

by | Sep 5, 2012 | antidepressants, clinical trials, conflicts of interest, drug marketing, ghostwriting, pharmaceutical industry, scientific journal retractions, scientific misconduct

I just learned that Dr. Martin Keller, principal investigator of the controversial Paxil study 329, has retired from his position as a professor of psychiatry at Brown University — see here. As Pharmalot notes, Keller quietly retired June 30 in the midst of an...

Calls for action against authors of controversial Paxil study are getting louder

by | Sep 4, 2012 | antidepressants, clinical trials, conflicts of interest, drug marketing, ghostwriting, National Institutes of Health, pharmaceutical industry, scientific journal retractions, scientific misconduct, university industry collaboration

In the wake of GlaxoSmithKline’s record-breaking $3 billion settlement with the U.S. Department of Justice, a number of psychiatrists and researchers have redoubled their efforts to get Paxil study 329 retracted. As mentioned here and in other news accounts, the...